Status:

COMPLETED

A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects

Lead Sponsor:

Lumosa Therapeutics Co., Ltd.

Conditions:

Acute Ischemic Stroke

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

This Phase 1 study is planned to establish the clinical safety and pharmacokinetics profile of multiple dose of LT3001 drug product and to investigate drug interactions of LT3001 with potential concom...

Detailed Description

This study is a two-part study. Part A is double-blind, placebo-controlled, and will examine the safety and PK profiles of multiple doses of LT3001 drug product in healthy subjects. Part B is open-lab...

Eligibility Criteria

Inclusion

  • Subject's body weight is ≥50 kg and BMI is within the range of 18 to 32
  • Subject is a healthy volunteer.
  • Subject's PT, aPTT, and TT are within the normal laboratory range.
  • Subject is a nonsmoker

Exclusion

  • Subject has a current or recent history of regular alcohol consumption.
  • Subjects who are enrolled in Part B and allergic to acetylsalicylic acid, other salicylates, clopidogrel, thienopyridines (eg, ticlopidine, prasugrel), apixaban or dabigatran.
  • Part B Cohort 2 only: subjects who are poor metabolizers of clopidogrel (CYP2C19\*2/\*2, \*2/\*3, or \*3/\*3 genotype)
  • Subject has a presence or history of coagulation abnormality.
  • Subjects need to receive a surgery or clinical procedures associated with high bleeding risk.
  • Subject has a history of minor bleeding episodes, eg, epistaxis, rectal bleeding, gingival bleeding.
  • Subject has a history of peptic ulcer or gastrointestinal bleeding.

Key Trial Info

Start Date :

March 21 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 5 2021

Estimated Enrollment :

65 Patients enrolled

Trial Details

Trial ID

NCT04809818

Start Date

March 21 2021

End Date

August 5 2021

Last Update

December 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lumosa Phase 1 Unit

Cypress, California, United States, 90630